Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Galapagos NV
Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.
IPO Date: March 1, 2012
Sector: Healthcare
Industry: Biotech
Market Cap: $1.89B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.92 | 1.16%
Avg Daily Range (30 D): $0.33 | 1.21%
Avg Daily Range (90 D): $0.32 | 1.24%
Institutional Daily Volume
Avg Daily Volume: .16M
Avg Daily Volume (30 D): .36M
Avg Daily Volume (90 D): .31M
Trade Size
Avg Trade Size (Sh.): 76
Avg Trade Size (Sh.) (30 D): 62
Avg Trade Size (Sh.) (90 D): 65
Institutional Trades
Total Inst.Trades: 1,137
Avg Inst. Trade: $2.43M
Avg Inst. Trade (30 D): $1.33M
Avg Inst. Trade (90 D): $1.72M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.19M
Avg Closing Trade (30 D): $.86M
Avg Closing Trade (90 D): $.97M
Avg Closing Volume: 34.86K
   
News
Jun 5, 2025 @ 5:00 AM
Planisware expands into Belgium to support the sus...
Source: N/A
Apr 15, 2025 @ 5:30 AM
Galapagos kondigt het vertrek van haar CFO en COO,...
Source: N/A
Apr 15, 2025 @ 5:30 AM
Galapagos Announces Departure of Thad Huston, CFO ...
Source: N/A
Jan 8, 2025 @ 7:07 PM
Galapagos Unveils 2025 Split To Accelerate Innovat...
Source: Vandana Singh
Jan 8, 2025 @ 6:30 AM
Galapagos wil aandeelhouderswaarde ontgrendelen me...
Source: N/A